Creative Medical Tech Files 8-K on Shareholder Votes & Financials
Ticker: CELZ · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1187953
| Field | Detail |
|---|---|
| Company | Creative Medical Technology Holdings, INC. (CELZ) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-actions, financials
Related Tickers: CMED
TL;DR
CMED filed an 8-K on 12/19/25 covering shareholder votes and financials as of 12/18/25.
AI Summary
Creative Medical Technology Holdings, Inc. filed an 8-K on December 19, 2025, reporting on matters submitted to a vote of security holders and financial statements as of December 18, 2025. The company, formerly known as Jolley Marketing Inc., is incorporated in Nevada and headquartered in Phoenix, Arizona.
Why It Matters
This filing indicates important corporate actions and financial reporting, which could signal upcoming strategic moves or performance updates for investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate actions and financial reporting, not indicating immediate significant risk.
Key Players & Entities
- Creative Medical Technology Holdings, Inc. (company) — Registrant
- Jolley Marketing Inc. (company) — Former company name
- December 18, 2025 (date) — Date of earliest event reported
- December 19, 2025 (date) — Filing date
- Phoenix, AZ (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the significance of the financial statements being reported?
The filing states that financial statements and exhibits are being reported, which typically provide an update on the company's financial condition and performance as of the reporting date.
When was Creative Medical Technology Holdings, Inc. formerly known as Jolley Marketing Inc.?
The company changed its name from Jolley Marketing Inc. on September 10, 2002.
Where are the principal executive offices of Creative Medical Technology Holdings, Inc. located?
The principal executive offices are located at 211 E Osborn Road, Phoenix, AZ 85012.
What is the SIC code for Creative Medical Technology Holdings, Inc.?
The Standard Industrial Classification (SIC) code for the company is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 628 words · 3 min read · ~2 pages · Grade level 12.3 · Accepted 2025-12-19 16:01:58
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CELZ The Nasdaq Stock Mar
Filing Documents
- celz_8k.htm (8-K) — 36KB
- 0001477932-25-009094.txt ( ) — 146KB
- celz-20251218.xsd (EX-101.SCH) — 5KB
- celz-20251218_lab.xml (EX-101.LAB) — 14KB
- celz-20251218_cal.xml (EX-101.CAL) — 1KB
- celz-20251218_pre.xml (EX-101.PRE) — 9KB
- celz-20251218_def.xml (EX-101.DEF) — 2KB
- celz_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 18, 2025, Creative Medical Technology Holdings, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on proposals for (i) the election of the director nominees named in the definitive proxy statement (the "Proxy Statement") for the Annual Meeting filed with the Securities and Exchange Commission on October 30, 2025 ("Proposal I"); (ii) the approval of the compensation of the Company's named executive officers ("Proposal II"); and (iii) the ratification of the appointment of Haynie & Company to serve as the Company's independent registered public accountants ("Proposal III"). Each of the foregoing proposals is described in more detail in the Proxy Statement. Stockholders holding an aggregate of 1,589,800 shares of common stock, representing 61.5% of the outstanding shares of the Company's common stock as of the record date, and which constituted a quorum, were present in person or represented by proxy at the Annual Meeting. The results of the voting at the Annual Meeting are presented below. Proposal I - The five director nominees were all elected to the Board as follows: Director For Withhold Timothy Warbington 434,037 42,240 Donald Dickerson 434,834 41,443 Michael H. Finger 423,050 53,227 Susan Snow 420,645 55,632 Bruce S. Urdang, Esq. 419,951 56,326 Proposal II - The compensation of the Company's named executive officers was approved as follows: For Against Abstain Broker Non-Votes 335,623 108,092 32,561 1,113,524 Proposal III –The ratification of the appointment of Haynie & Company was approved as follows: For Against Abstain Broker Non-Votes 1,346,871 115,979 126,950 N/A 2
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Creative Medical Technology Holdings, Inc. Date: December 19, 2025 By: /s/ Timothy Warbington Timothy Warbington, Chief Executive Officer 4